Carlos Nueno - Nov 29, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, International
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Nov 29, 2024
Transactions value $
-$60,948
Form type
4
Date filed
12/3/2024, 05:30 PM
Previous filing
Sep 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.06K 1.06K Nov 29, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1.12K +106.34% 2.18K Nov 29, 2024 Direct F2
transaction TDOC Common Stock Options Exercise +3.1K +142.27% 5.28K Nov 29, 2024 Direct F2
transaction TDOC Common Stock Sale -$28.5K -2.39K -45.25% $11.93 2.89K Dec 2, 2024 Direct F3
transaction TDOC Common Stock Sale -$32.5K -2.89K -100% $11.23 0 Dec 3, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1.06K -16.65% $0.00 5.29K Nov 29, 2024 Common Stock 1.06K Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -1.12K -50% $0.00 1.12K Nov 29, 2024 Common Stock 1.12K Direct F2, F6
transaction TDOC Restricted Stock Units Options Exercise $0 -3.1K -16.66% $0.00 15.5K Nov 29, 2024 Common Stock 3.1K Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 6, 2023.
F5 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.